文献速递产科母胎医学

辅助生殖技术受孕早产儿的神经发育结局

Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology.
PubMed 文献 · Am J Obstet Gynecol · 2021-03-30

这项回顾性队列研究纳入2010至2016年加拿大10个新生儿随访网络诊所中出生胎龄<29周的活产无畸形早产儿,比较辅助生殖技术受孕与自然受孕者在矫正年龄18至24个月的神经发育结局。多变量分析显示,辅助生殖技术受孕与神经发育障碍、死亡或神经发育障碍复合结局、Bayley-III认知和语言复合评分<85的 odds 降低相关。

要点

  • 辅助生殖技术受孕与早产儿神经发育障碍 odds 降低相关(aOR 0.67, 95%CI 0.52-0.86)。
  • 辅助生殖技术受孕与死亡或神经发育障碍复合结局 odds 降低相关(aOR 0.67, 95%CI 0.54-0.84)。
  • 辅助生殖技术受孕与Bayley-III认知和语言评分<85的 odds 降低相关。

核心结论

  • 与自然受孕相比,辅助生殖技术受孕与出生胎龄<29周早产儿在矫正年龄18至24个月时不良神经发育结局(尤其认知和语言结局)的 odds 降低相关。

研究设计与样本

  • 回顾性队列研究纳入2010年1月1日至2016年12月31日出生胎龄<29周、在加拿大10个新生儿随访网络诊所任一机构于矫正年龄18至24个月接受神经发育评估的院内出生无畸形婴儿。
  • 共4863名合格新生儿,其中651名(13.4%)通过辅助生殖技术受孕。
  • 存活婴儿4176名,其中3386名(81%)在矫正年龄18至24个月有随访结局。

主要发现

  • 辅助生殖技术组母亲年龄、教育水平及糖尿病、产前皮质类固醇使用和剖宫产率均高于自然受孕组。
  • 新生儿发病率和死亡率相似,但辅助生殖技术组脑室内出血发生率较低(33% [181/546] vs 39% [1284/3318];P=.01)。
  • 多变量 logistic 回归调整后,辅助生殖技术受孕与神经发育障碍 odds 降低相关(aOR 0.67;95%CI 0.52-0.86)。
  • 辅助生殖技术受孕与死亡或神经发育障碍复合结局 odds 降低相关(aOR 0.67;95%CI 0.54-0.84)。
  • 辅助生殖技术受孕与Bayley-III认知复合评分<85(aOR 0.68;95%CI 0.48-0.99)和语言复合评分<85(aOR 0.67;95%CI 0.50-0.88)的 odds 降低相关。

关键数值与推荐

  • 主要结局为矫正年龄18至24个月神经发育障碍,定义为脑瘫、Bayley-III认知/运动/语言复合评分<85、感音神经性或混合性听力损失、单侧或双侧视觉障碍中任一存在。
  • 多变量 logistic 回归调整了胎龄、产前类固醇、性别、小于胎龄儿、多胎妊娠、分娩方式、母亲年龄、母亲教育、妊娠期高血压、母亲糖尿病和吸烟。

临床怎么用

  • 对于出生胎龄<29周的早产儿,辅助生殖技术受孕本身不应被视为神经发育不良结局的额外危险因素。
  • 仍需对辅助生殖技术受孕早产儿进行长期随访,以评估学龄期学习障碍及复杂视觉空间和处理技能发育风险。

局限性

  • 原文未报告本研究的具体局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There have been concerns about the development of children conceived through assisted reproductive technology. Despite multiple studies investigating the outcomes of assisted conception, data focusing specifically on the neurodevelopmental outcomes of infants conceived through assisted reproductive technology and born preterm are limited. OBJECTIVE: This study aimed to evaluate and compare the neurodevelopmental outcomes of preterm infants born at <29 weeks' gestation at 18 to 24 months' corrected age who were conceived through assisted reproductive technology and those who were conceived naturally. STUDY DESIGN: This retrospective cohort study included inborn, nonanomalous infants, born at <29 weeks' gestation between January 1, 2010, and December 31, 2016, who had a neurodevelopmental assessment at 18 to 24 months' corrected age at any of the 10 Canadian Neonatal Follow-Up Network clinics. The primary outcome was neurodevelopmental impairment at 18 to 24 months, defined as the presence of any of the following: cerebral palsy; Bayley-III cognitive, motor, or language composite score of <85; sensorineural or mixed hearing loss; and unilateral or bilateral visual impairment. Secondary outcomes included mortality, composite of mortality or neurodevelopmental impairment, significant neurodevelopmental impairment, and each component of the primary outcome. We compared outcomes between infants conceived through assisted reproductive technology and those conceived naturally, using bivariate and multivariable analyses after adjustment. RESULTS: Of the 4863 eligible neonates, 651 (13.4%) were conceived using assisted reproductive technology. Maternal age; education level; and rates of diabetes mellitus, receipt of antenatal corticosteroids, and cesarean delivery were higher in the assisted reproduction group than the natural conception group. Neonatal morbidity and death rates were similar except for intraventricular hemorrhage, which was lower in the assisted reproduction group (33% [181 of 546] vs 39% [1284 of 3318]; P=.01). Of the 4176 surviving infants, 3386 (81%) had a follow-up outcome at 18 to 24 months' corrected age. Multivariable logistic regression adjusting for gestational age, antenatal steroids, sex, small for gestational age, multiple gestations, mode of delivery, maternal age, maternal education, pregnancy-induced hypertension, maternal diabetes mellitus, and smoking showed that infants conceived through assisted reproduction was associated with lower odds of neurodevelopmental impairment (adjusted odds ratio, 0.67; 95% confidence interval, 0.52-0.86) and the composite of death or neurodevelopmental impairment (adjusted odds ratio, 0.67; 95% confidence interval, 0.54-0.84). Conception through assisted reproductive technology was associated with decreased odds of a Bayley-III composite cognitive score of <85 (adjusted odds ratio, 0.68; 95% confidence interval, 0.48-0.99) and composite language score of <85 (adjusted odds ratio, 0.67; 95% confidence interval, 0.50-0.88). CONCLUSION: Compared with natural conception, assisted conception was associated with lower odds of adverse neurodevelopmental outcomes, especially cognitive and language outcomes, at 18 to 24 months' corrected age among preterm infants born at <29 weeks' gestation. Long-term follow-up studies are required to assess the risks of learning disabilities and development of complex visual-spatial and processing skills in these children as they reach school age.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Roychoudhury S, Lodha A, Synnes A, et al. Neurodevelopmental outcomes of preterm infants conceived by assisted reproductive technology. Am J Obstet Gynecol. 2021. PMID: 33798481. doi:10.1016/j.ajog.2021.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。